Skip to main content

Table 2 Summary of 16 cases of CMF-OS, including the present cases

From: Chondromyxoid fibroma-like osteosarcoma: a case series and literature review

No.

Age

Sex

Site

Radiology

Biopsy

Follow-up

Reference

1

34 y

F

5th finger

unknown

CMF

recurrence, 4 y

Mirra, 1989 [3]

2

unknown

unknown

unknown

unknown

CMF

recurrence, 12 y

Mirra, 1989 [3]

3

39 y

F

maxilla

soft tissue mass

myxoma

recurrence, 4 y

Chow, 1996 [4]

4

39 y

M

left iliac crest

osteolytic lesion; soft tissue mass with calcification

CHS

metastasis to the lung and liver, 6 y

Chow, 1996 [4]

5

25 y

F

right mandible

diffuse mixed-density lesion

OS

DFS, unknown

Sinha, 2010 [5]

6

45 y

M

left maxilla

poorly defined areas of sclerosis with few lytic areas

CMF

recurrence and metastasis to the brain, 5 mo

Prasad, 2015 [6]

7

13 mo

F

right maxillary sinus and nasal cavity

soft tissue mass with mild contrast enhancement and internal calcifications

CMF

AWD, 2 y

Lee, 2015 [7]

8

13 y

M

proximal right tibia metadiaphysis

large lytic, septate lesion with cortical destruction; soft tissue mass

OS

DFS, 6 mo

Stark, 2017 [8]

9

9 y

F

left femur

osteolytic, osteogenic lesion; soft tissue mass

OS

DFS, 6 mo

Liu, 2007 [9]

10

39 y

M

left femur

soft tissue mass

CHS

DFS 6 mo

Ma, 2016 [10]

11

21 y

F

proximal left femur

osteogenic lesion

OS

metastasis to the lung, 7 mo

Present case

12

37 y

F

left 2nd rib

expansive lesions

CMF

DFS, 20 mo

Present case

13

56 y

F

3rd toe

destruction, soft tissue mass

mixed tumour

DFS, 39 mo

Present case

14

51 y

M

nasal cavity

soft tissue mass

CMF

recurrence, 13 mo; AWD, another 8 mo

Present case

15

27 y

M

right mandible

soft tissue mass

OS

DFS, 4 mo

Present case

16

50 y

M

left maxilla

soft tissue mass

CMF

metastasis to the lung, 2 mo; AWD, another 7 mo

Present case

  1. F Female, M Male, CMF-OS Chondromyxoid fibroma-like osteosarcoma, CMF Chondromyxoid fibroma, CHS Chondrosarcoma, OS Osteosarcoma, AWD Alive with disease, DFS Disease-free survival, y Years, mo Months